Phospho-PKC gamma (Thr514) Antibody - #AF8347
Product: | Phospho-PKC gamma (Thr514) Antibody |
Catalog: | AF8347 |
Description: | Rabbit polyclonal antibody to Phospho-PKC gamma (Thr514) |
Application: | WB IF/ICC |
Reactivity: | Human, Rat |
Prediction: | Pig, Bovine, Horse, Sheep, Rabbit, Dog |
Mol.Wt.: | 75 KD; 78kD(Calculated). |
Uniprot: | P05129 |
RRID: | AB_2840409 |
Related Downloads
Protocols
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# AF8347, RRID:AB_2840409.
Fold/Unfold
KPCG_HUMAN; MGC57564; OTTHUMP00000067291; PKC-gamma; PKCC; PKCG; PRKCG; Protein kinase C gamma; Protein kinase C gamma polypeptide; Protein kinase C gamma type; Protein kinase C, gamma; SCA 14; SCA14;
Immunogens
- P05129 KPCG_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MAGLGPGVGDSEGGPRPLFCRKGALRQKVVHEVKSHKFTARFFKQPTFCSHCTDFIWGIGKQGLQCQVCSFVVHRRCHEFVTFECPGAGKGPQTDDPRNKHKFRLHSYSSPTFCDHCGSLLYGLVHQGMKCSCCEMNVHRRCVRSVPSLCGVDHTERRGRLQLEIRAPTADEIHVTVGEARNLIPMDPNGLSDPYVKLKLIPDPRNLTKQKTRTVKATLNPVWNETFVFNLKPGDVERRLSVEVWDWDRTSRNDFMGAMSFGVSELLKAPVDGWYKLLNQEEGEYYNVPVADADNCSLLQKFEACNYPLELYERVRMGPSSSPIPSPSPSPTDPKRCFFGASPGRLHISDFSFLMVLGKGSFGKVMLAERRGSDELYAIKILKKDVIVQDDDVDCTLVEKRVLALGGRGPGGRPHFLTQLHSTFQTPDRLYFVMEYVTGGDLMYHIQQLGKFKEPHAAFYAAEIAIGLFFLHNQGIIYRDLKLDNVMLDAEGHIKITDFGMCKENVFPGTTTRTFCGTPDYIAPEIIAYQPYGKSVDWWSFGVLLYEMLAGQPPFDGEDEEELFQAIMEQTVTYPKSLSREAVAICKGFLTKHPGKRLGSGPDGEPTIRAHGFFRWIDWERLERLEIPPPFRPRPCGRSGENFDKFFTRAAPALTPPDRLVLASIDQADFQGFTYVNPDFVHPDARSPTSPVPVPVM
Predictions
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P05129 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S109 | Phosphorylation | Uniprot | |
S145 | Phosphorylation | Uniprot | |
S148 | Phosphorylation | Uniprot | |
T155 | Phosphorylation | Uniprot | |
Y195 | Phosphorylation | Uniprot | |
K197 | Acetylation | Uniprot | |
K197 | Ubiquitination | Uniprot | |
S264 | Phosphorylation | Uniprot | |
S320 | Phosphorylation | Uniprot | |
S342 | Phosphorylation | Uniprot | |
K359 | Acetylation | Uniprot | |
K359 | Ubiquitination | Uniprot | |
S361 | Phosphorylation | Uniprot | |
K503 | Acetylation | Uniprot | |
T510 | Phosphorylation | Uniprot | |
T511 | Phosphorylation | Uniprot | |
T512 | Phosphorylation | Uniprot | |
T514 | Phosphorylation | Uniprot | |
T518 | Phosphorylation | Uniprot | |
Y521 | Phosphorylation | Uniprot | |
Y529 | Phosphorylation | Uniprot | |
T655 | Phosphorylation | Uniprot | |
T674 | Phosphorylation | Uniprot |
PTMs - P05129 As Enzyme
Substrate | Site | Source |
---|---|---|
O94768 (STK17B) | S351 | Uniprot |
P04004 (VTN) | S381 | Uniprot |
P04049 (RAF1) | S497 | Uniprot |
P04049 (RAF1) | S619 | Uniprot |
P04083 (ANXA1) | S27 | Uniprot |
P06127 (CD5) | T434 | Uniprot |
P06127 (CD5) | T436 | Uniprot |
P06730-1 (EIF4E) | S209 | Uniprot |
P07900 (HSP90AA1) | T115 | Uniprot |
P07900 (HSP90AA1) | T425 | Uniprot |
P07900 (HSP90AA1) | T603 | Uniprot |
P08138 (NGFR) | S277 | Uniprot |
P10636-8 (MAPT) | S258 | Uniprot |
P10636-8 (MAPT) | S293 | Uniprot |
P10636-8 (MAPT) | S324 | Uniprot |
P10636-8 (MAPT) | S352 | Uniprot |
P11388-1 (TOP2A) | S29 | Uniprot |
P17302 (GJA1) | S368 | Uniprot |
P19429 (TNNI3) | S42 | Uniprot |
P19429 (TNNI3) | S44 | Uniprot |
P21730 (C5AR1) | S334 | Uniprot |
P25098 (GRK2) | S29 | Uniprot |
P28329-3 (CHAT) | T255 | Uniprot |
P28329-3 (CHAT) | S346 | Uniprot |
P28329-3 (CHAT) | S347 | Uniprot |
P28329 (CHAT) | T373 | Uniprot |
P28329-3 (CHAT) | S440 | Uniprot |
P28329 (CHAT) | S464 | Uniprot |
P28329 (CHAT) | S465 | Uniprot |
P28329-3 (CHAT) | S476 | Uniprot |
P28329 (CHAT) | S558 | Uniprot |
P28329 (CHAT) | S594 | Uniprot |
P29474 (NOS3) | T495 | Uniprot |
P30086 (PEBP1) | S153 | Uniprot |
P34741 (SDC2) | S187 | Uniprot |
P34741 (SDC2) | S188 | Uniprot |
P35568 (IRS1) | S1101 | Uniprot |
P41180 (CASR) | T888 | Uniprot |
P41594-2 (GRM5) | S840 | Uniprot |
P43629 (KIR3DL1) | S415 | Uniprot |
P48058 (GRIA4) | S862 | Uniprot |
P49619 (DGKG) | S779 | Uniprot |
P49619 (DGKG) | S782 | Uniprot |
P49768 (PSEN1) | S346 | Uniprot |
P49840 (GSK3A) | S21 | Uniprot |
P49841 (GSK3B) | S9 | Uniprot |
P50281 (MMP14) | T567 | Uniprot |
P61764-2 (STXBP1) | S306 | Uniprot |
P61764-1 (STXBP1) | S313 | Uniprot |
P98082 (DAB2) | S24 | Uniprot |
Q03721 (KCNC4) | S8 | Uniprot |
Q03721 (KCNC4) | S9 | Uniprot |
Q03721 (KCNC4) | S15 | Uniprot |
Q03721 (KCNC4) | S21 | Uniprot |
Q05586 (GRIN1) | S890 | Uniprot |
Q13224 (GRIN2B) | S1303 | Uniprot |
Q13224 (GRIN2B) | S1323 | Uniprot |
Q14155 (ARHGEF7) | S518 | Uniprot |
Q14155 (ARHGEF7) | S761 | Uniprot |
Q16625-1 (OCLN) | S340 | Uniprot |
Q5JVS0-1 (HABP4) | T354 | Uniprot |
Q5JVS0 (HABP4) | T375 | Uniprot |
Q7Z2E3 (APTX) | T125 | Uniprot |
Q92686 (NRGN) | S36 | Uniprot |
Q99418-2 (CYTH2) | S391 | Uniprot |
Q99418-1 (CYTH2) | S392 | Uniprot |
Q9UBS0 (RPS6KB2) | S473 | Uniprot |
Q9UQ80-1 (PA2G4) | S363 | Uniprot |
Q9UQ80-1 (PA2G4) | T366 | Uniprot |
Research Backgrounds
Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays diverse roles in neuronal cells and eye tissues, such as regulation of the neuronal receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and neuronal functions related to sensitivity to opiates, pain and alcohol, mediation of synaptic function and cell survival after ischemia, and inhibition of gap junction activity after oxidative stress. Binds and phosphorylates GRIA4/GLUR4 glutamate receptor and regulates its function by increasing plasma membrane-associated GRIA4 expression. In primary cerebellar neurons treated with the agonist 3,5-dihyidroxyphenylglycine, functions downstream of the metabotropic glutamate receptor GRM5/MGLUR5 and phosphorylates GRIN1/NMDAR1 receptor which plays a key role in synaptic plasticity, synaptogenesis, excitotoxicity, memory acquisition and learning. May be involved in the regulation of hippocampal long-term potentiation (LTP), but may be not necessary for the process of synaptic plasticity. May be involved in desensitization of mu-type opioid receptor-mediated G-protein activation in the spinal cord, and may be critical for the development and/or maintenance of morphine-induced reinforcing effects in the limbic forebrain. May modulate the functionality of mu-type-opioid receptors by participating in a signaling pathway which leads to the phosphorylation and degradation of opioid receptors. May also contributes to chronic morphine-induced changes in nociceptive processing. Plays a role in neuropathic pain mechanisms and contributes to the maintenance of the allodynia pain produced by peripheral inflammation. Plays an important role in initial sensitivity and tolerance to ethanol, by mediating the behavioral effects of ethanol as well as the effects of this drug on the GABA(A) receptors. During and after cerebral ischemia modulate neurotransmission and cell survival in synaptic membranes, and is involved in insulin-induced inhibition of necrosis, an important mechanism for minimizing ischemic injury. Required for the elimination of multiple climbing fibers during innervation of Purkinje cells in developing cerebellum. Is activated in lens epithelial cells upon hydrogen peroxide treatment, and phosphorylates connexin-43 (GJA1/CX43), resulting in disassembly of GJA1 gap junction plaques and inhibition of gap junction activity which could provide a protective effect against oxidative stress (By similarity). Phosphorylates p53/TP53 and promotes p53/TP53-dependent apoptosis in response to DNA damage. Involved in the phase resetting of the cerebral cortex circadian clock during temporally restricted feeding. Stabilizes the core clock component ARNTL/BMAL1 by interfering with its ubiquitination, thus suppressing its degradation, resulting in phase resetting of the cerebral cortex clock (By similarity).
Autophosphorylation on Thr-674 appears to regulate motor functions of junctophilins, JPH3 and JPH4.
Ubiquitinated.
Cytoplasm. Cytoplasm>Perinuclear region. Cell membrane>Peripheral membrane protein. Cell junction>Synapse>Synaptosome. Cell projection>Dendrite.
Note: Translocates to synaptic membranes on stimulation.
Expressed in Purkinje cells of the cerebellar cortex.
Interacts with GRIA4 (By similarity). Interacts with CDCP1. Interacts with TP53INP1 and p53/TP53. Interacts with ARNTL/BMAL1 (By similarity).
Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.
Research Fields
· Cellular Processes > Cellular community - eukaryotes > Focal adhesion. (View pathway)
· Cellular Processes > Cellular community - eukaryotes > Gap junction. (View pathway)
· Environmental Information Processing > Signal transduction > MAPK signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > ErbB signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Ras signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Rap1 signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Calcium signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > HIF-1 signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Phosphatidylinositol signaling system.
· Environmental Information Processing > Signal transduction > Sphingolipid signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > mTOR signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Wnt signaling pathway. (View pathway)
· Human Diseases > Drug resistance: Antineoplastic > EGFR tyrosine kinase inhibitor resistance.
· Human Diseases > Substance dependence > Amphetamine addiction.
· Human Diseases > Substance dependence > Morphine addiction.
· Human Diseases > Infectious diseases: Parasitic > African trypanosomiasis.
· Human Diseases > Infectious diseases: Parasitic > Amoebiasis.
· Human Diseases > Infectious diseases: Viral > Hepatitis B.
· Human Diseases > Cancers: Overview > Pathways in cancer. (View pathway)
· Human Diseases > Cancers: Overview > Proteoglycans in cancer.
· Human Diseases > Cancers: Overview > MicroRNAs in cancer.
· Human Diseases > Cancers: Specific types > Glioma. (View pathway)
· Human Diseases > Cancers: Specific types > Non-small cell lung cancer. (View pathway)
· Human Diseases > Cancers: Specific types > Hepatocellular carcinoma. (View pathway)
· Human Diseases > Cancers: Overview > Choline metabolism in cancer. (View pathway)
· Organismal Systems > Circulatory system > Vascular smooth muscle contraction. (View pathway)
· Organismal Systems > Immune system > Natural killer cell mediated cytotoxicity. (View pathway)
· Organismal Systems > Immune system > Fc gamma R-mediated phagocytosis. (View pathway)
· Organismal Systems > Immune system > Leukocyte transendothelial migration. (View pathway)
· Organismal Systems > Environmental adaptation > Circadian entrainment.
· Organismal Systems > Nervous system > Long-term potentiation.
· Organismal Systems > Nervous system > Retrograde endocannabinoid signaling. (View pathway)
· Organismal Systems > Nervous system > Glutamatergic synapse.
· Organismal Systems > Nervous system > Cholinergic synapse.
· Organismal Systems > Nervous system > Serotonergic synapse.
· Organismal Systems > Nervous system > GABAergic synapse.
· Organismal Systems > Nervous system > Dopaminergic synapse.
· Organismal Systems > Nervous system > Long-term depression.
· Organismal Systems > Sensory system > Inflammatory mediator regulation of TRP channels. (View pathway)
· Organismal Systems > Endocrine system > Insulin secretion. (View pathway)
· Organismal Systems > Endocrine system > Melanogenesis.
· Organismal Systems > Endocrine system > Thyroid hormone synthesis.
· Organismal Systems > Endocrine system > Thyroid hormone signaling pathway. (View pathway)
· Organismal Systems > Endocrine system > Oxytocin signaling pathway.
· Organismal Systems > Endocrine system > Aldosterone synthesis and secretion.
· Organismal Systems > Excretory system > Aldosterone-regulated sodium reabsorption.
· Organismal Systems > Excretory system > Endocrine and other factor-regulated calcium reabsorption.
· Organismal Systems > Digestive system > Salivary secretion.
· Organismal Systems > Digestive system > Gastric acid secretion.
· Organismal Systems > Digestive system > Pancreatic secretion.
References
Application: WB Species: human Sample: H1299-WT, KD and OV cells
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.